TherapeuticsMD Inc

NASDAQ TXMD

Data sourced from iex and EODHD
Download Data

TherapeuticsMD Inc Revenue for the year ending December 31, 2023: USD 1.30 M

TherapeuticsMD Inc Revenue is USD 1.30 M for the year ending December 31, 2023, a -98.14% change year over year. The revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • TherapeuticsMD Inc Revenue for the year ending December 31, 2022 was USD 69.96 M, a -19.54% change year over year.
  • TherapeuticsMD Inc Revenue for the year ending December 31, 2021 was USD 86.95 M, a 34.03% change year over year.
  • TherapeuticsMD Inc Revenue for the year ending December 31, 2020 was USD 64.87 M, a 30.67% change year over year.
  • TherapeuticsMD Inc Revenue for the year ending December 31, 2019 was USD 49.65 M, a 208.38% change year over year.
NASDAQ: TXMD

TherapeuticsMD Inc

CEO Governor Thomas G. Thompson
IPO Date Dec. 11, 2003
Location United States
Headquarters 951 Yamato Road, Boca Raton, FL, United States, 33431
Employees 1
Sector Healthcare
Industry Drug manufacturers - specialty & generic
Description

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Similar companies

EGRX

Eagle Pharmaceuticals Inc

NA

NA

CYTH

Cyclo Therapeutics Inc

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email